Back to Search
Start Over
mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to Pegaspargase
- Source :
- Koo, G., Anvari, S., Friedman, D.L., Zarnegar-Lumley, S., Szafron, V., Kahwash, B.M., Onasch, K.M., Hall, L., Phillips, E.J. <
- Publication Year :
- 2021
-
Abstract
- Pegaspargase is a vital component of a multidrug chemotherapy regimen for treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL)...
Details
- Database :
- OAIster
- Journal :
- Koo, G., Anvari, S., Friedman, D.L., Zarnegar-Lumley, S., Szafron, V., Kahwash, B.M., Onasch, K.M., Hall, L., Phillips, E.J. <
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1359382378
- Document Type :
- Electronic Resource